Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy

被引：0
|
作者：
Paola Paci
Rossella Carello
Massimo Bernaschi
Gianpiero D'Offizi
Filippo Castiglione
机构：
[1] National Research Council,Institute for Computing Applications "Mauro Picone"
[2] I.R.C.C.S.,National Institute for Infectious Diseases "Lazzaro Spallanzani"
[3] San Pietro Hospital,Research Center
[4] Fatebenefratelli,undefined
[5] AFaR,undefined
来源：
BMC Infectious Diseases | / 9卷
关键词：
Human Immunodeficiency Virus; Viral Rebound; Plasma Viremia; Public Health Expenditure; Nucleic Acid Sequence Base Amplification;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Unintended HIV-1 Infection During Analytical Therapy Interruption
    Ugarte, Ainoa
    Romero, Yolanda
    Tricas, Amparo
    Casado, Concepcion
    Lopez-Galindez, Cecilio
    Garcia, Felipe
    Leal, Lorna
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (10): : 1740 - 1742
  • [22] Effect of early versus deferred antiretroviral therapy for HIV on survival
    Calvo A., Mario
    REVISTA CHILENA DE INFECTOLOGIA, 2009, 26 (05): : 474 - 475
  • [23] Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice
    Ventura, John D.
    Beloor, Jagadish
    Allen, Edward
    Zhang, Tongyu
    Haugh, Kelsey A.
    Uchil, Pradeep D.
    Ochsenbauer, Christina
    Kieffer, Collin
    Kumar, Priti
    Hope, Thomas J.
    Mothes, Walther
    PLOS PATHOGENS, 2019, 15 (12)
  • [24] In HIV-1, immediate vs deferred antiretroviral therapy and isoniazid vs no isoniazid reduced severe illness at 30 mo
    Anglaret, X.
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (12)
  • [25] Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
    Kitahata, Mari M.
    Gange, Stephen J.
    Abraham, Alison G.
    Merriman, Barry
    Saag, Michael S.
    Justice, Amy C.
    Hogg, Robert S.
    Deeks, Steven G.
    Eron, Joseph J.
    Brooks, John T.
    Rourke, Sean B.
    Gill, M. John
    Bosch, Ronald J.
    Martin, Jeffrey N.
    Klein, Marina B.
    Jacobson, Lisa P.
    Rodriguez, Benigno
    Sterling, Timothy R.
    Kirk, Gregory D.
    Napravnik, Sonia
    Rachlis, Anita R.
    Calzavara, Liviana M.
    Horberg, Michael A.
    Silverberg, Michael J.
    Gebo, Kelly A.
    Goedert, James J.
    Benson, Constance A.
    Collier, Ann C.
    Van Rompaey, Stephen E.
    Crane, Heidi M.
    McKaig, Rosemary G.
    Lau, Bryan
    Freeman, Aimee M.
    Moore, Richard D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18): : 1815 - 1826
  • [26] Delayed HIV-1 seroconversion after antiretroviral therapy
    Apetrei, C
    Tamalet, C
    Edlinger, C
    Damond, F
    Descamps, D
    Saimot, AG
    Brun-Vézinet, F
    Simon, F
    AIDS, 1998, 12 (14) : 1935 - 1936
  • [27] Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection
    Hocqueloux, Laurent
    Prazuck, Thierry
    Avettand-Fenoel, Veronique
    Lafeuillade, Alain
    Cardon, Bernard
    Viard, Jean-Paul
    Rouzioux, Christine
    AIDS, 2010, 24 (10) : 1598 - 1601
  • [28] Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV
    Pelchen-Matthews, Annegret
    Mocroft, Amanda
    Ryom, Lene
    Ross, Michael J.
    Sharma, Shweta
    Coca, Steven
    Achhra, Amit
    Cornell, Elaine
    Tracy, Russell
    Phillips, Andrew
    Alonso, Marta Montero
    Toulomi, Giota
    Agan, Brian K.
    Medland, Nicholas
    Wyatt, Christina M.
    KIDNEY INTERNATIONAL, 2024, 106 (01) : 136 - 144
  • [29] Unmasking tuberculosis-associated immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy
    Pornprasert, Sakorn
    Leechanachai, Pranee
    Klinbuayaem, Virat
    Leenasirimakul, Prattana
    Promping, Channat
    Inta, Prasit
    Ajhan, Siraporn
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2010, 28 (2-3): : 206 - 209
  • [30] Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption
    Gondim, Marcos V. P.
    Sherrill-Mix, Scott
    Bibollet-Ruche, Frederic
    Russell, Ronnie M.
    Trimboli, Stephanie
    Smith, Andrew G.
    Li, Yingying
    Liu, Weimin
    Avitto, Alexa N.
    DeVoto, Julia C.
    Connell, Jesse
    Fenton-May, Angharad E.
    Pellegrino, Pierre
    Williams, Ian
    Papasavvas, Emmanouil
    Lorenzi, Julio C. C.
    Salantes, D. Brenda
    Mampe, Felicity
    Monroy, M. Alexandra
    Cohen, Yehuda Z.
    Heath, Sonya
    Saag, Michael S.
    Montaner, Luis J.
    Collman, Ronald G.
    Siliciano, Janet M.
    Siliciano, Robert F.
    Plenderleith, Lindsey J.
    Sharp, Paul M.
    Caskey, Marina
    Nussenzweig, Michel C.
    Shaw, George M.
    Borrow, Persephone
    Bar, Katharine J.
    Hahn, Beatrice H.
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (576)
12345